EP 2709646 A4 20150513 - DRY POWDER VANCOMYCIN COMPOSITIONS AND ASSOCIATED METHODS
Title (en)
DRY POWDER VANCOMYCIN COMPOSITIONS AND ASSOCIATED METHODS
Title (de)
TROCKENPULVER-VANCOMYCINZUSAMMENSETZUNGEN UND ZUGEHÖRIGE VERFAHREN
Title (fr)
COMPOSITIONS DE POUDRE SÈCHE DE VANCOMYCINE ET MÉTHODES ASSOCIÉES
Publication
Application
Priority
- US 201161487971 P 20110519
- US 2012038775 W 20120521
Abstract (en)
[origin: WO2012159103A1] Dry powder vancomycin compositions and methods for administering and preparing such compositions. A composition of the present disclosure may be administered to a subject via pulmonary administration in an amount effective to treat and/or prevent a bacterial infection in the subject. Administration of an effective amount of a composition of the present disclosure may be particularly useful in treating a gram-positive bacterial infection in a subject suffering from pneumonia, cystic fibrosis, bronchiectasis, or other chronic lung disease with a bacterial infection of the subject's airway and/or lung.
IPC 8 full level
A61K 38/14 (2006.01)
CPC (source: EP IL KR)
A61K 9/0075 (2013.01 - EP IL KR); A61K 9/1617 (2013.01 - EP IL KR); A61K 9/4808 (2013.01 - KR); A61K 31/198 (2013.01 - EP KR); A61K 38/14 (2013.01 - EP KR); A61P 11/00 (2017.12 - EP); A61P 31/00 (2017.12 - EP); A61P 31/04 (2017.12 - EP); A61K 2121/00 (2013.01 - KR); A61K 2300/00 (2013.01 - KR)
C-Set (source: EP)
Citation (search report)
- [XY] WO 0132144 A1 20010510 - INHALE THERAPEUTIC SYST [US], et al
- [Y] WO 9741833 A1 19971113 - INHALE THERAPEUTIC SYST [US]
- [Y] WO 03037303 A1 20030508 - INHALE THERAPEUTIC SYST [US], et al
- [Y] WO 0113893 A2 20010301 - ADVANCED INHALATION RES INC [US], et al
- [XP] PRAJAKTA S. GADGILP: "A comparative study between high potency dry powder inhalation and nebulized solution of vancomycin hydrochloride for lung delivery", 11 August 2011 (2011-08-11), pages FP - 109, XP055140679, Retrieved from the Internet <URL:http://search.proquest.com/pqdtscieng/docview/889930798as02134> [retrieved on 20141111]
- [Y] REINHARD VEHRING: "Pharmaceutical Particle Engineering via Spray Drying", PHARMACEUTICAL RESEARCH, vol. 25, no. 5, 28 November 2007 (2007-11-28), KLUWER ACADEMIC PUBLISHERS-PLENUM PUBLISHERS, NL, pages 999 - 1022, XP019613056, ISSN: 1573-904X
- [Y] M. J. DE JESUS VALLE ET AL: "Pulmonary versus Systemic Delivery of Antibiotics: Comparison of Vancomycin Dispositions in the Isolated Rat Lung", ANTIMICROBIAL AGENTS AND CHEMOTHERAPY, vol. 51, no. 10, 6 August 2007 (2007-08-06), pages 3771 - 3774, XP055140353, ISSN: 0066-4804, DOI: 10.1128/AAC.00099-07
- [A] ANONYMOUS: "Handbook of Pharmaceutical Excipients. Fifth Edition", 2006, PHARMACEUTICAL PRESS, article "Leucine", pages: 412, XP002729817
- See references of WO 2012159103A1
Designated contracting state (EPC)
AL AT BE BG CH CY CZ DE DK EE ES FI FR GB GR HR HU IE IS IT LI LT LU LV MC MK MT NL NO PL PT RO RS SE SI SK SM TR
DOCDB simple family (publication)
WO 2012159103 A1 20121122; AU 2012254999 B2 20160211; BR 112013029803 A2 20170117; BR 112013029803 B1 20210713; CA 2836643 A1 20121122; CA 2836643 C 20171114; CA 2981038 A1 20121122; CA 2981038 C 20180925; CN 103717231 A 20140409; CN 103717231 B 20160817; EP 2709646 A1 20140326; EP 2709646 A4 20150513; IL 229506 A0 20140130; IL 229506 B 20190731; JP 2014515356 A 20140630; JP 6012716 B2 20161025; KR 101763195 B1 20170731; KR 20140032450 A 20140314; MX 2013013503 A 20140512; MX 346244 B 20170313; NZ 618002 A 20150327; NZ 704819 A 20160527; SG 195038 A1 20131230
DOCDB simple family (application)
US 2012038775 W 20120521; AU 2012254999 A 20120521; BR 112013029803 A 20120521; CA 2836643 A 20120521; CA 2981038 A 20120521; CN 201280035537 A 20120521; EP 12785744 A 20120521; IL 22950613 A 20131119; JP 2014511611 A 20120521; KR 20137033895 A 20120521; MX 2013013503 A 20120521; NZ 61800212 A 20120521; NZ 70481912 A 20120521; SG 2013085394 A 20120521